Zobrazeno 1 - 5
of 5
pro vyhledávání: '"William T Wang"'
Autor:
William T. Wang, Anne Hellkamp, Jacob A. Doll, Laine Thomas, Ann Marie Navar, Gregg C. Fonarow, Howard M. Julien, Eric D. Peterson, Tracy Y. Wang
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 3 (2018)
BackgroundThe 2013 American College of Cardiology/American Heart Association cholesterol guidelines recommend high‐intensity statins for patients after myocardial infarction (MI) rather than treating to a low‐density lipoprotein cholesterol goal,
Externí odkaz:
https://doaj.org/article/a39fa29882854876933f046b9dbcb36b
Autor:
Tracy Y. Wang, William T Wang, Robin Mathews, Laine Thomas, Lisa A. Kaltenbach, Rashmee U. Shah, Eric D. Peterson, Murtuza J. Ali
Publikováno v:
Circulation. 137:2128-2138
Background: Medication adherence is important to improve the long-term outcomes after acute myocardial infarction (MI). We hypothesized that there is significant variation among US hospitals in terms of medication adherence after MI, and that patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f5fe1d2ceca27c86771b0e055f52522
https://doi.org/10.1161/circulationaha.117.029160
https://doi.org/10.1161/circulationaha.117.029160
Over the past decade, more men than women have shown improved outcomes from antithrombotic therapies after acute coronary syndrome (ACS), which raises the question of whether there are sex-specific differences in treatment patterns and response to th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e56489bff1a3783ce3e4fb4146458fd
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-319665
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-319665
Autor:
Laine Thomas, Eric D. Peterson, Jacob A. Doll, Anne S. Hellkamp, William T Wang, Tracy Y. Wang, Howard Julien, Anne M Navar, Gregg C. Fonarow
Publikováno v:
Circulation: Cardiovascular Quality and Outcomes. 9
Background: The 2013 ACC/AHA cholesterol guidelines recommend high intensity statin use for all post-myocardial infarction (MI) patients, instead of treating to a low density lipoprotein cholesterol (LDL-C) goal on follow-up lipid testing. We examine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65409ef4badb9a70d0837aab382223b0
https://doi.org/10.1161/circoutcomes.9.suppl_2.9
https://doi.org/10.1161/circoutcomes.9.suppl_2.9
Autor:
William T. Wang, Laine Thomas, Gregg C. Fonarow, Tracy Y. Wang, Eric D. Peterson, Jacob A. Doll, Anne S. Hellkamp
Publikováno v:
Journal of the American College of Cardiology. 67:532
While ezetimibe has been approved for lipid lowering in the U.S. since 2002, the IMPROVE-IT trial only recently demonstrated its benefit on clinical outcomes when added to a statin in post-myocardial infarction (MI) patients. We examined patterns of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::618c22e9e952fb5fef070bc9d81f17ae
https://doi.org/10.1016/s0735-1097(16)30533-2
https://doi.org/10.1016/s0735-1097(16)30533-2